Novo Nordisk A/S
STABLE SEMAGLUTIDE COMPOSITIONS AND USES THEREOF
Last updated:
Abstract:
The present invention relates to pharmaceutical compositions of the GLP-1 peptide semaglutide comprising a stabilizer such as histidine, their preparation, kits comprising such compositions as well as medical uses thereof.
Status:
Application
Type:
Utility
Filling date:
25 Oct 2019
Issue date:
9 Dec 2021